发明名称 IMMUNOGLOBULINS WITH REDUCED AGGREGATION
摘要 The present disclosure relates to immunoglobulins with reduced aggregation and compositions, methods of generating such immunoglobulins with computational tools and methods of using such immunoglobulins particularly in the treatment and prevention of disease.
申请公布号 US2014348820(A1) 申请公布日期 2014.11.27
申请号 US201414265149 申请日期 2014.04.29
申请人 Novartis AG ;MASSACHUSETTS INSTITUTE OF TECHNOLOGY 发明人 CHENNAMSETTY Naresh;HELK Bernhard;KAYSER Veysel;TROUT Bernhardt;VOYNOV Vladimir
分类号 C07K16/18 主分类号 C07K16/18
代理机构 代理人
主权项 1. A modified or isolated immunoglobulin having reduced propensity for aggregation comprising at least one aggregation reducing mutation at a residue in a conserved domain of the immunoglobulin that (i) has a Spatial-Aggregation-Propensity (5 Å radius sphere) of at least 0.15, or (ii) has an Spatial-Aggregation-Propensity (5 Å radius sphere) of greater than 0.0 and is within 5 Å of a residue having a Spatial-Aggregation-Propensity (5 Å radius sphere) of at least 0.15, wherein the at least one aggregation reducing mutation is a substitution with an amino acid residue that lowers the Spatial-Aggregation-Propensity (5 Å radius sphere) of the residue as compared to the unmutated immunoglobulin and the propensity for aggregation that is reduced is aggregation between immunoglobulin molecules in a concentrated, liquid solution, wherein the at least one aggregation reducing mutation is not residue 234 (hinge) or 235 (hinge).
地址 Basel CH